Stock jumps 12% on regulatory approval of new shot
Novavax Inc.’s NVAX, +10.58% new COVID shot got a green light from the U.S. Food and Drug Administration Tuesday.
Novavax shares jumped more than 12% Tuesday on news of the approval. The stock has dropped more than 21% in the year to date, while the S&P 500 SPX has gained 10%.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novavax Stock Jumps After FDA Approves Updated Covid VaccineShares were up more than 10% on the news, which came more than three weeks after vaccines from Moderna and Pfizer.
Read more »
US FDA authorizes Novavax's updated COVID shot By ReutersUS FDA authorizes Novavax's updated COVID shot
Read more »
FDA approves updated Novavax Covid vaccine as Pfizer, Moderna shots roll out in U.S.Health officials see Novavax's protein-based vaccine as a valuable alternative for people who don't want to take messenger RNA shots from Pfizer and Moderna.
Read more »
FDA Authorizes Novavax’s Updated Covid VaccineThe shot has been updated to target a strain of the coronavirus that was circulating earlier this year.
Read more »
FDA authorizes updated Novavax Covid vaccine as Pfizer, Moderna shots roll out in U.S.Health officials see Novavax’s protein-based vaccine as a valuable alternative for people who don’t want to take messenger RNA shots from Pfizer and Moderna.
Read more »
Fantasy Football Stock Up, Stock DownWith a quarter of the NFL season in the books, here’s a look at some of the biggest fantasy winners ... and a few disappointments.
Read more »